RVMD Revolution Medicines, Inc.
$203.77▲ +0.21%
Healthcare
Other
After hours
$203.32▼ -0.22%
Sep 11, 7:51 PM ET
Volume 1.38M
Avg Volume (10D) 1.52M
Key Metrics & Fundamentals
Market Cap
$43.68B
P/E Ratio
–
Div Yield
–%
52W Range
42.18 - 224.31
% vs 50 MA
2.79%
% vs 200 MA
49.00%
RSI-14
48.4
MACD Histogram
-1.9200
Beta (1Y vs SPY)
1.13
Free Cash Flow
-$745.31M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$460.52M
COGS
–
Operating Exp
$505.13M
Operating Income
-$505.13M
EBIT
-$505.13M
Pretax Income
-$644.37M
Net Income
-$644.37M
EPS (Diluted)
-3.06
Price & Volume History
Loading chart…
Recent News

MarketBeat Week in Review – 09/07 - 09/11
MarketBeat · Sep 12, 2026 11:00 AM

Revolution Medicines (RVMD) Gets its First Approved Drug, and the Market Shrugs
Insider Monkey · Sep 12, 2026 12:40 AM

Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · Sep 11, 2026 3:49 PM
Revolution Medicines Insider Sold Shares Worth $3,585,837, According to a Recent SEC Filing
MT Newswires · Sep 10, 2026 9:59 PM

Revolution Medicines Got a ‘Miracle’ Cancer Drug Approval. Wall Street Wants More.
Barrons.com · Sep 10, 2026 6:40 PM
Revolution Medicines to Gain From Drug Expansion, New Combination Therapies, Morgan Stanley Says
MT Newswires · Sep 10, 2026 3:29 PM
Update: Morgan Stanley Initiates Revolution Medicines With Overweight Rating, $255 Price Target
MT Newswires · Sep 10, 2026 11:57 AM
Morgan Stanley Initiates Coverage on Revolution Medicines With Overweight Rating
MT Newswires · Sep 10, 2026 11:33 AM

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial
GlobeNewswire · Sep 8, 2026 12:17 PM

Revolution Medicines (RVMD) Stock Looks Overvalued Even After Its Drug Approval
Simply Wall St. · Sep 5, 2026 2:13 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See RVMD's money flow as a full page
Social Sentiment
Avg +0.42 · 5 posts
NewsDiscussionThe market thinks Revolution Medicines(RVMD)is a biotech. I think it’s becoming big pharma
r/stocks · Jul 24, 2026
The post is bullish on RVMD and highlights positive Phase 3 results of their drug.
positive
+0.80
TradeRelief rally is on. My system kept me long through the scary week... how are your trades doing?
r/stocks · Jun 15, 2026
The post explicitly mentions RVMD and its performance (+2.9%).
positive
+0.30
DiscussionNewsSaving Millions and Making Millions, now more than ever
r/stocks · May 21, 2026
User highlights the company's potential despite perceived challenges, indicating interest and concern.
positive
+0.80
Too late for RVMD?
r/stocks · Apr 13, 2026
The post indicates a positive reaction to a clinical breakthrough, with a significant stock jump and optimistic projections for future trials.
positive
+0.80
list of all pre-revenue companies sorted by market capitalization.
r/stocks · Sep 24, 2025
The post highlights the speculative nature of companies with no revenue or products, suggesting RVMD's high valuation is unjustified.
negative
-0.60
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.